195 related articles for article (PubMed ID: 29445085)
1. Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIP
Zhang N; Liu X; Liu L; Deng Z; Zeng Q; Pang W; Liu Y; Song D; Deng H
Cell Death Dis; 2018 Feb; 9(2):230. PubMed ID: 29445085
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.
Marchand B; Arsenault D; Raymond-Fleury A; Boisvert FM; Boucher MJ
J Biol Chem; 2015 Feb; 290(9):5592-605. PubMed ID: 25561726
[TBL] [Abstract][Full Text] [Related]
3. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling.
Fang G; Zhang P; Liu J; Zhang X; Zhu X; Li R; Wang H
Cancer Lett; 2019 Oct; 463():11-26. PubMed ID: 31404613
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin induces autophagy-mediated c-FLIPL degradation and leads to apoptosis in human non-small cell lung cancer cells.
Yu X; Ling J; Liu X; Guo S; Lin Y; Liu X; Su L
Oncotarget; 2017 Jan; 8(4):6691-6699. PubMed ID: 28035061
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3β antagonizes ROS-induced hepatocellular carcinoma cell death through suppression of the apoptosis signal-regulating kinase 1.
Zhang N; Liu L; Dou Y; Song D; Deng H
Med Oncol; 2016 Jul; 33(7):60. PubMed ID: 27221474
[TBL] [Abstract][Full Text] [Related]
7. MPB, a novel berberine derivative, enhances lysosomal and bactericidal properties via TGF-β-activated kinase 1-dependent activation of the transcription factor EB.
Liu X; Zhang N; Liu Y; Liu L; Zeng Q; Yin M; Wang Y; Song D; Deng H
FASEB J; 2019 Jan; 33(1):1468-1481. PubMed ID: 30161000
[TBL] [Abstract][Full Text] [Related]
8. Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice.
Huang H; Xue J; Xie ML; Xie T
Strahlenther Onkol; 2024 May; 200(5):444-452. PubMed ID: 37963994
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
10. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
11. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
12. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
14. Anesthetic propofol causes glycogen synthase kinase-3β-regulated lysosomal/mitochondrial apoptosis in macrophages.
Hsing CH; Chen YH; Chen CL; Huang WC; Lin MC; Tseng PC; Wang CY; Tsai CC; Choi PC; Lin CF
Anesthesiology; 2012 Apr; 116(4):868-81. PubMed ID: 22334036
[TBL] [Abstract][Full Text] [Related]
15. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells.
Sun A; Li C; Chen R; Huang Y; Chen Q; Cui X; Liu H; Thrasher JB; Li B
Prostate; 2016 Feb; 76(2):172-83. PubMed ID: 26440826
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
17. mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3β.
Bautista SJ; Boras I; Vissa A; Mecica N; Yip CM; Kim PK; Antonescu CN
J Biol Chem; 2018 Sep; 293(38):14723-14739. PubMed ID: 30061153
[TBL] [Abstract][Full Text] [Related]
18. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
[TBL] [Abstract][Full Text] [Related]
19. Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression.
Hwang IH; Oh SY; Jang HJ; Jo E; Joo JC; Lee KB; Yoo HS; Lee MY; Park SJ; Jang IS
PLoS One; 2017; 12(10):e0186489. PubMed ID: 29045468
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
